Mark Fortner Logo

Mark Fortner

Software, services and advice for drug discovery companies

At Aspen Biosciences we create technology solutions for drug discovery and cancer research organisations. Our clients include ActivX Biosciences, aTyr Pharmaceuticals, Dart Neuroscience, Eli Lilly, Pfizer, Novartis and the Dana Farber Cancer Institute. Past projects include ELN/LIMS selection and implementation, custom kinase profiling tools, custom genomic reagent and compound management applications, assay management systems and portfolio and project management applications. Our mission is to help our customers succeed in discovering new medicines.

Industry: Biotech/Pharma
Primary Expertise: Drug discovery consulting
Secondary Expertise: IT, LIMS, bioinformatics, and software services and consulting

Connect: Email LinkedIn Twitter